Methods for preparing pyridylethyl-substituted carbolines
WO2009039420A1
Methods and compositions for treating neuronal death mediated ocular diseases
BRPI0815850A2
"method for treating, slowing down progression, preventing or delaying the development of schizophrenia in an individual, pharmaceutically acceptable composition, kit and method of strengthening an anti-response response"
CA2691812A1
A drug demonstrating anxiolytic effect based on hydrogenated pyrido (4,3-b) indoles, its pharmacological compound and application method
AU2008257152A1
Methods and compositions for stimulating cells
WO2008073231A1
Means for the treatment of acute and chronic disorders of cerebral circulation, including insult, based on hydrogenated pyrido (4, 3-b) indoles (variants), pharmacological means based thereon and method for the use thereof
EP2086538A2
Combination therapies for treating alzheimer's disease using dimebon and donepezil
CA2664098A1
Compounds and method for treating canine cognitive dysfunction syndrome
AU2007297539A1
Methods and compositions for treating amyotrophic lateral sclerosis (ALS)
AU2007208223A1
Methods and compositions for treating schizophrenia